ES8101890A1 - Un procedimiento para preparar una forma de dosificacion de una vacuna de una cepa avirulenta atenuada de bordetella - bronchiseptica. - Google Patents
Un procedimiento para preparar una forma de dosificacion de una vacuna de una cepa avirulenta atenuada de bordetella - bronchiseptica.Info
- Publication number
- ES8101890A1 ES8101890A1 ES487816A ES487816A ES8101890A1 ES 8101890 A1 ES8101890 A1 ES 8101890A1 ES 487816 A ES487816 A ES 487816A ES 487816 A ES487816 A ES 487816A ES 8101890 A1 ES8101890 A1 ES 8101890A1
- Authority
- ES
- Spain
- Prior art keywords
- vaccine
- procedure
- bronchiseptica
- bordetella
- sterile water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
PROCEDIMIENTO DE DOSIFICACION DE UNA VACUNA DE UNA CEPA AVIRULENTA ATENUADA DE BORDETELLA BRONCHISEPTICA. CONSTA DE LAS SIGUIENTES OPERACIONES: 1) CULTIVO EN UN MEDIO NUTRIENTE ACUOSO DE LA CEPA BORDETELLA BRONCHISEPTICA ATCC N. 31437, O DE UNA CEPA DERIVADA DE ESTA. SE OBTIENE UNA SUSPENSION ACUOSA DE UNA CONCENTRACION DE AL MENOS 1 X 10 ELEVADO A 7 CELULAS VIABLES POR MILILITRO. 2) ADICION DE UNA SOLUCION ACUOSA DE UN CRIOPROTECTOR MICROBIOLOGICO Y MEDIOS DE ESTABILIZACION. 3) LIOFILIZACION DE LA SUSPENSION CELULAR DILUIDA. 4) INTRODUCCION DE UNA CANTIDAD MEDIDA DE LAS CELULAS LIOFILIZADAS EN UN VIAL DE VACUNA PARA EL ALMACENAMIENTO Y TRANSPORTE DE LA VACUNA. SE AÑADE AGUA ESTERIL EN UNA PROPORCION DE AL MENOS UN 25 POR 100 MENOS QUE EL VOLUMEN DE AGUA RETIRADA POR LA LIOFILIZACION. EL AGUA ESTERIL CONTIENE UN AGENTE HUMECTANTE ANIONICO O NO IONICO. TRATAMIENTO DE RINITIS ATROFICA EN CERDOS Y DE TOS CANINA (TRAQUEOBRONQUITIS) EN PERROS.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96747878A | 1978-12-07 | 1978-12-07 | |
| US05/967,477 US4225583A (en) | 1978-12-07 | 1978-12-07 | Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use |
| EP79810169A EP0012718B1 (en) | 1978-12-07 | 1979-11-30 | Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES487816A0 ES487816A0 (es) | 1980-12-16 |
| ES8101890A1 true ES8101890A1 (es) | 1980-12-16 |
Family
ID=27224630
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES486579A Expired ES486579A1 (es) | 1978-12-07 | 1979-12-04 | Un procedimiento para preparar una vacuna intra-respiratoria |
| ES487816A Expired ES8101890A1 (es) | 1978-12-07 | 1980-01-18 | Un procedimiento para preparar una forma de dosificacion de una vacuna de una cepa avirulenta atenuada de bordetella - bronchiseptica. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES486579A Expired ES486579A1 (es) | 1978-12-07 | 1979-12-04 | Un procedimiento para preparar una vacuna intra-respiratoria |
Country Status (2)
| Country | Link |
|---|---|
| AT (1) | ATE212T1 (es) |
| ES (2) | ES486579A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
-
1979
- 1979-11-30 AT AT79810169T patent/ATE212T1/de not_active IP Right Cessation
- 1979-12-04 ES ES486579A patent/ES486579A1/es not_active Expired
-
1980
- 1980-01-18 ES ES487816A patent/ES8101890A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES486579A1 (es) | 1980-10-01 |
| ES487816A0 (es) | 1980-12-16 |
| ATE212T1 (de) | 1981-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abelseth | An attenuated rabies vaccine for domestic animals produced in tissue culture | |
| Jones | The effect of temperature, solids content and pH on the survival of salmonellas in cattle slurry | |
| Bey et al. | Protein-free and low-protein media for the cultivation of Leptospira | |
| Chahal et al. | Decomposition of organic matter in Sanborn field soils amended with C14 glucose | |
| GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
| KR830000909A (ko) | 호흡기내 백신 제조방법 | |
| Boissevain et al. | A note on the effect of synthetic ascorbic acid (vitamin C) on the growth of the tubercle bacillus | |
| ES459086A1 (es) | Procedimiento de obtencion de nuevas aril (trifluoretil) a- minas. | |
| Reid et al. | The influence of X-radiation on mortality following thermal flash burns: the site of tissue injury as a factor determining the type of invading bacteria | |
| Cunningham | Parenteral administration of copper as cerate to cattle and sheep | |
| Ljunggren | Transfer of virulence in Rhizobium trifolii | |
| ES436028A1 (es) | Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta. | |
| Kahrs et al. | Observations on the intranasal vaccination of pregnant cattle against infectious bovine rhinotracheitis and parainfluenza-3 virus infection | |
| IE792348L (en) | Intra-respiratory vaccine | |
| Stalheim | Viable, avirulent Leptospira interrogans serotype pomona vaccine: Preservation in liquid nitrogen | |
| Birkhaug | Antigenic activity of fresh, frozen, and dry BCG vaccine | |
| RU2259214C1 (ru) | Способ получения вакцины оспенной инактивированной сухой "оспавир" | |
| ES313427A1 (es) | Un metodo para la preparacion de una vacuna de brucella abortus viviente. | |
| GB1015262A (en) | Virus culture | |
| Heddleston et al. | Vaccination of American bison against Pasteurella multocida serotype 2 infection (hemorrhagic septicemia) | |
| Keppie et al. | Early appearance of colonies of Brucella spp. on solid media containing erythritol | |
| Schmitz et al. | Duration of viability and the growth and expiration rates of group E streptococci in soil | |
| HESSELVIK et al. | Active Basal Immunity and Its Application to Epidemiology IV. Initial Pain in Diphtheria‐Tetanus‐Pertussis Vaccination | |
| SU411130A1 (es) | ||
| GB1351343A (en) | Methods of preparation and use of a vaccine from bacteroides nodosus |